Role of nitric oxide and endothelin-1 in a portal hypertensive rat model

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 10, 2000, Pages 1097-1105

  Tsugawa, K ^a   Hashizurae, M ^a   Migou, S ^a   Kishihara, F ^a   Kawanaka, H ^a   Tomikawa, M ^a   Tanoue, K ^a   Sugimachi, K ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Endothelin 1; Nitric oxide; Portal hypertension

Indexed keywords

AMINOGUANIDINE; ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; ENZYME INHIBITION; LIVER; MALE; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; RAT; SPLEEN; STOMACH MUCOSA;

EID: 0033773190     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200451243     Document Type: Article

References (44)

1. Portal hypertension
2. Biology of portal hypertension
3. Hyperdynamic circulation in portal-hypertensive rat model: A primary factor maintenance of chronic portal hypertension
4. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension
5. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats
6. The diagnostic and predictive value of ascites nitric oxide levels in patients with spontaneous bacterial peritonitis
7. Portal hypertension activates the nitric oxide synthase genes in the esophageal mucosa of rats
8. 2-adrenocepter relaxation is impaired in mesenteric veins from portal-hypertensive rats
9. Acute and chronic cyclooxygenase blockade in portal-hypertensive rats: Influence on nitric oxide biosynthesis
10. Increased blood hemoglobin attenuates splanchnic vasodilatation in portal-hypertensive rats by nitric oxide inactivation
11. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats
12. Mesenteric vasodilatation responses in cirrhotic rats: A role for nitric oxide?
13. Prostaglandins modulate the responsiveness of the gastric microcirculation to sodium nitroprusside in cirrhotic rats
14. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats
15. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats
16. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis
17. Enhanced nitric oxide synthase activity in portal hypertensive rabbits
18. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites
19. Role of nitric oxide in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats
20. Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide
21. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages
22. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions
23. Chronic blockade of endothelin receptors in cirrhotic rats: Hepatic and hemodynamic effect
24. Beneficial hemodynamic effects of Bosentan, a mixed ETA and ETB receptor antagonist, in portal hypertensive rats
25. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: Role in splanchnic hemodynamics
26. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance
27. A rat model of esophageal varices
28. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy
29. Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy
30. Gastric mucosal blood flow in portal hypertension patients: A laser Doppler flowmetry study
31. Congestive gastropathy versus chronic gastritis: A comparison of some pathophysiological aspects
32. Reduced gastric mucosal blood flow in patients with portal-hypertensive gastropathy
33. Laser Doppler velocimetry: A new technique for the measurement of intestinal mucosal blood flow
34. Analysis of nitrate, nitrite, and (15)N-nitrate in biological fluids
35. Measurement of nitric oxide in biological models
36. Increased plasma endothelin-1 in pulmonary hypertension: Marker or mediator of disease?
37. Human pulmonary circulation is an important site for both clearance and production of endothelin-l
38. N(G)-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists
39. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction
40. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
41. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome
42. Circulating levels of endothelin in cirrhosis
43. Effects of endothelin in portal hypertensive rats
44. Vascular hyporesponsiveness to endothelin-1 in rats with cirrhosis